Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
NDSN Quote, Financials, Valuation and Earnings
Last price:
$209.71
Seasonality move
:
5.94%
Day range:
$207.15 - $213.87
52-week range:
$207.15 - $279.38
Dividend yield:
1.35%
P/E ratio:
25.86x
P/S ratio:
4.49x
P/B ratio:
4.08x
Volume:
920.6K
Avg. volume:
360.7K
1-year change:
-17.77%
Market cap:
$12B
Revenue:
$2.7B
EPS (TTM):
$8.11
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.4B | $2.6B | $2.6B | $2.7B | |
| Revenue Growth (YoY) | -3.33% | 11.37% | 9.66% | 1.48% | 2.33% | |
| Cost of Revenues | $990.6M | $1B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $1.1B | $1.3B | $1.4B | $1.4B | $1.5B | |
| Gross Profit Margin | 53.3% | 56.05% | 55.07% | 54.23% | 55.25% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $693.6M | $709M | $724.2M | $752.6M | $812.1M | |
| Other Inc / (Exp) | -$104.9M | -$17.6M | -$32.7M | -$597K | -$4.5M | |
| Operating Expenses | $693.6M | $709M | $724.2M | $752.6M | $812.1M | |
| Operating Income | $436.9M | $615.1M | $702.4M | $672.8M | $674M | |
| Net Interest Expenses | $30.5M | $23.3M | $20.4M | $56.8M | $84M | |
| EBT. Incl. Unusual Items | $301.5M | $574.2M | $649.3M | $615.3M | $585.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $52M | $119.8M | $136.2M | $127.8M | $118.2M | |
| Net Income to Company | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Basic EPS (Cont. Ops) | $4.32 | $7.82 | $8.90 | $8.54 | $8.17 | |
| Diluted EPS (Cont. Ops) | $4.27 | $7.74 | $8.81 | $8.46 | $8.11 | |
| Weighted Average Basic Share | $57.8M | $58.1M | $57.6M | $57.1M | $57.2M | |
| Weighted Average Diluted Share | $58.5M | $58.7M | $58.2M | $57.6M | $57.6M | |
| EBITDA | $447M | $703.6M | $771.6M | $786.7M | $810.6M | |
| EBIT | $333.6M | $599.7M | $671.7M | $674.8M | $674.4M | |
| Revenue (Reported) | $2.1B | $2.4B | $2.6B | $2.6B | $2.7B | |
| Operating Income (Reported) | $436.9M | $615.1M | $702.4M | $672.8M | $674M | |
| Operating Income (Adjusted) | $333.6M | $599.7M | $671.7M | $674.8M | $674.4M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $558.5M | $599.2M | $683.6M | $719.3M | $744.5M | |
| Revenue Growth (YoY) | -4.6% | 7.29% | 14.07% | 5.23% | 3.5% | |
| Cost of Revenues | $261.7M | $268.1M | $320.4M | $335.2M | $341.7M | |
| Gross Profit | $296.9M | $331.2M | $363.2M | $384.1M | $402.8M | |
| Gross Profit Margin | 53.15% | 55.26% | 53.13% | 53.4% | 54.11% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $172.1M | $179.7M | $185.6M | $199.1M | $223.9M | |
| Other Inc / (Exp) | -$92M | -$6.9M | $5M | $1.5M | -$3.5M | |
| Operating Expenses | $172.1M | $179.7M | $185.6M | $199.1M | $223.9M | |
| Operating Income | $124.7M | $151.4M | $177.6M | $185M | $178.9M | |
| Net Interest Expenses | $6.4M | $4.5M | $5.1M | $25.9M | $27.3M | |
| EBT. Incl. Unusual Items | $26.3M | $140.1M | $177.5M | $160.6M | $148.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.8M | $29.6M | $36.3M | $32.8M | $25.9M | |
| Net Income to Company | $18.5M | $110.5M | $141.2M | $127.8M | $122.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $18.5M | $110.5M | $141.2M | $127.8M | $122.2M | |
| Basic EPS (Cont. Ops) | $0.32 | $1.90 | $2.47 | $2.24 | $2.14 | |
| Diluted EPS (Cont. Ops) | $0.31 | $1.88 | $2.44 | $2.22 | $2.12 | |
| Weighted Average Basic Share | $58M | $58.1M | $57.2M | $57M | $57.2M | |
| Weighted Average Diluted Share | $58.7M | $58.8M | $57.8M | $57.6M | $57.6M | |
| EBITDA | $62.3M | $171M | $207.9M | $218.8M | $213.2M | |
| EBIT | $33.1M | $145.4M | $183.2M | $187.6M | $176.6M | |
| Revenue (Reported) | $558.5M | $599.2M | $683.6M | $719.3M | $744.5M | |
| Operating Income (Reported) | $124.7M | $151.4M | $177.6M | $185M | $178.9M | |
| Operating Income (Adjusted) | $33.1M | $145.4M | $183.2M | $187.6M | $176.6M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.4B | $2.6B | $2.6B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $990.6M | $1B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $1.1B | $1.3B | $1.4B | $1.4B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $693.6M | $709M | $724.2M | $752.6M | $812.1M | |
| Other Inc / (Exp) | -$104.9M | -$17.6M | -$32.7M | -$597K | -$4.5M | |
| Operating Expenses | $693.6M | $709M | $724.2M | $752.6M | $812.1M | |
| Operating Income | $436.9M | $615.1M | $702.4M | $672.8M | $674M | |
| Net Interest Expenses | $30.5M | $23.3M | $20.4M | $56.8M | $84M | |
| EBT. Incl. Unusual Items | $301.5M | $574.2M | $649.3M | $615.3M | $585.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $52M | $119.8M | $136.2M | $127.8M | $118.2M | |
| Net Income to Company | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Basic EPS (Cont. Ops) | $4.33 | $7.83 | $8.91 | $8.53 | $8.18 | |
| Diluted EPS (Cont. Ops) | $4.27 | $7.74 | $8.82 | $8.46 | $8.11 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $447M | $703.6M | $771.6M | $786.7M | $810.6M | |
| EBIT | $333.6M | $599.7M | $671.7M | $674.8M | $674.4M | |
| Revenue (Reported) | $2.1B | $2.4B | $2.6B | $2.6B | $2.7B | |
| Operating Income (Reported) | $436.9M | $615.1M | $702.4M | $672.8M | $674M | |
| Operating Income (Adjusted) | $333.6M | $599.7M | $671.7M | $674.8M | $674.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.6B | $2.6B | $2.7B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.2B | $1.2B | $1.2B | -- | |
| Gross Profit | $1.3B | $1.4B | $1.4B | $1.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $709M | $724.2M | $752.6M | $812.1M | -- | |
| Other Inc / (Exp) | -$17.6M | -$32.7M | -$597K | -$4.5M | -- | |
| Operating Expenses | $709M | $724.2M | $752.6M | $812.1M | -- | |
| Operating Income | $615.1M | $702.4M | $672.8M | $674M | -- | |
| Net Interest Expenses | $23.3M | $20.4M | $56.8M | $84M | -- | |
| EBT. Incl. Unusual Items | $574.2M | $649.3M | $615.3M | $585.5M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $119.8M | $136.2M | $127.8M | $118.2M | -- | |
| Net Income to Company | $454.4M | $513.1M | $487.5M | $467.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $454.4M | $513.1M | $487.5M | $467.3M | -- | |
| Basic EPS (Cont. Ops) | $7.83 | $8.91 | $8.53 | $8.18 | -- | |
| Diluted EPS (Cont. Ops) | $7.74 | $8.82 | $8.46 | $8.11 | -- | |
| Weighted Average Basic Share | $232.4M | $230.5M | $228.4M | $228.7M | -- | |
| Weighted Average Diluted Share | $234.9M | $233M | $230.5M | $230.5M | -- | |
| EBITDA | $703.6M | $771.6M | $786.7M | $810.6M | -- | |
| EBIT | $599.7M | $671.7M | $674.8M | $674.4M | -- | |
| Revenue (Reported) | $2.4B | $2.6B | $2.6B | $2.7B | -- | |
| Operating Income (Reported) | $615.1M | $702.4M | $672.8M | $674M | -- | |
| Operating Income (Adjusted) | $599.7M | $671.7M | $674.8M | $674.4M | -- | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $445.4M | $479.6M | $502.1M | $548.4M | $561.6M | |
| Inventory | $277M | $327.2M | $383.4M | $454.8M | $476.9M | |
| Prepaid Expenses | $43.8M | $48.3M | -- | -- | -- | |
| Other Current Assets | -- | -- | $48.8M | $68M | $87.5M | |
| Total Current Assets | $1B | $1.2B | $1.1B | $1.2B | $1.3B | |
| Property Plant And Equipment | $480.7M | $466.4M | $455.7M | $499M | $638.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.7B | $1.7B | $1.8B | $2.8B | $3.3B | |
| Other Intangibles | $407.6M | $357.4M | $329.4M | $672.7M | $740.8M | |
| Other Long-Term Assets | $42.5M | $77.8M | $87.1M | $50.5M | $54.8M | |
| Total Assets | $3.7B | $3.8B | $3.8B | $5.3B | $6B | |
| Accounts Payable | $70.9M | $91.7M | $99.3M | $106.3M | $97.8M | |
| Accrued Expenses | $144.3M | $183.3M | $175.8M | $165.6M | $186.6M | |
| Current Portion Of Long-Term Debt | $38M | $34.2M | $392.5M | $115.7M | $103.9M | |
| Current Portion Of Capital Lease Obligations | $22.9M | $23M | $20.6M | $21.8M | $22.3M | |
| Other Current Liabilities | $13.1M | -- | $11.7M | $10.4M | $16.2M | |
| Total Current Liabilities | $363.1M | $445.4M | $834.2M | $582.1M | $528.5M | |
| Long-Term Debt | $1.1B | $781.7M | $345.3M | $1.6B | $2.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $1.6B | $1.5B | $2.7B | $3.1B | |
| Common Stock | $12.3M | $12.3M | $12.3M | $12.3M | $12.3M | |
| Other Common Equity Adj | -$226.1M | -$175.8M | -$207.8M | -$196.4M | -$184.8M | |
| Common Equity | $1.8B | $2.2B | $2.3B | $2.6B | $2.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $2.2B | $2.3B | $2.6B | $2.9B | |
| Total Liabilities and Equity | $3.7B | $3.8B | $3.8B | $5.3B | $6B | |
| Cash and Short Terms | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Total Debt | $1.1B | $815.9M | $737.9M | $1.7B | $2.2B | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $445.4M | $479.6M | $502.1M | $548.4M | $561.6M | |
| Inventory | $277M | $327.2M | $383.4M | $454.8M | $476.9M | |
| Prepaid Expenses | $43.8M | $48.3M | -- | -- | -- | |
| Other Current Assets | -- | -- | $48.8M | $68M | $87.5M | |
| Total Current Assets | $1B | $1.2B | $1.1B | $1.2B | $1.3B | |
| Property Plant And Equipment | $480.7M | $466.4M | $455.7M | $499M | $638.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.7B | $1.7B | $1.8B | $2.8B | $3.3B | |
| Other Intangibles | $407.6M | $357.4M | $329.4M | $672.7M | $740.8M | |
| Other Long-Term Assets | $42.5M | $77.8M | $87.1M | $50.5M | $54.8M | |
| Total Assets | $3.7B | $3.8B | $3.8B | $5.3B | $6B | |
| Accounts Payable | $70.9M | $91.7M | $99.3M | $106.3M | $97.8M | |
| Accrued Expenses | $144.3M | $183.3M | $175.8M | $165.6M | $186.6M | |
| Current Portion Of Long-Term Debt | $38M | $34.2M | $392.5M | $115.7M | $103.9M | |
| Current Portion Of Capital Lease Obligations | $22.9M | $23M | $20.6M | $21.8M | $22.3M | |
| Other Current Liabilities | $13.1M | -- | $11.7M | $10.4M | $16.2M | |
| Total Current Liabilities | $363.1M | $445.4M | $834.2M | $582.1M | $528.5M | |
| Long-Term Debt | $1.1B | $781.7M | $345.3M | $1.6B | $2.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $1.6B | $1.5B | $2.7B | $3.1B | |
| Common Stock | $12.3M | $12.3M | $12.3M | $12.3M | $12.3M | |
| Other Common Equity Adj | -$226.1M | -$175.8M | -$207.8M | -$196.4M | -$184.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $2.2B | $2.3B | $2.6B | $2.9B | |
| Total Liabilities and Equity | $3.7B | $3.8B | $3.8B | $5.3B | $6B | |
| Cash and Short Terms | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Total Debt | $1.1B | $815.9M | $737.9M | $1.7B | $2.2B | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Depreciation & Amoritzation | $113.3M | $103.9M | $99.9M | $111.9M | $136.2M | |
| Stock-Based Compensation | $12.9M | $22.8M | $30.7M | $22.7M | $19M | |
| Change in Accounts Receivable | $50.1M | -$13.7M | -$72.9M | $18.2M | $14M | |
| Change in Inventories | $5.8M | -$50.6M | -$69.1M | $22.4M | $46.6M | |
| Cash From Operations | $502.4M | $545.9M | $513.1M | $641.3M | $556.2M | |
| Capital Expenditures | $50.5M | $38.3M | $51.4M | $34.6M | $64.4M | |
| Cash Acquisitions | -$142.4M | -- | -$171.6M | -$1.4B | -$790M | |
| Cash From Investing | -$194.1M | -$33.2M | -$222.8M | -$1.4B | -$844.4M | |
| Dividends Paid (Ex Special Dividend) | -$88.3M | -$97.7M | -$125.9M | -$150.4M | -$161.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $165.7M | $9.4M | $63.1M | $2.2B | $783M | |
| Long-Term Debt Repaid | -$327.2M | -$305.5M | -$102.4M | -$1.2B | -$324.8M | |
| Repurchase of Common Stock | -$52.6M | -$61M | -$262.9M | -$89.7M | -$33.3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$251.5M | -$422.9M | -$416M | $750.5M | $294.5M | |
| Beginning Cash (CF) | $151.2M | $208.3M | $300M | $163.5M | $115.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $56.8M | $89.8M | -$125.6M | -$45.1M | $6.3M | |
| Ending Cash (CF) | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Levered Free Cash Flow | $451.9M | $507.6M | $461.7M | $606.7M | $491.8M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $18.5M | $110.5M | $141.2M | $127.8M | $122.2M | |
| Depreciation & Amoritzation | $29.1M | $25.7M | $24.7M | $31.3M | $36.5M | |
| Stock-Based Compensation | $3.9M | $4.7M | $7.3M | $5.6M | $4.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $192.5M | $170.5M | $173.4M | $163.2M | $96.4M | |
| Capital Expenditures | $14.4M | $10.2M | $12.1M | $10.3M | $20.6M | |
| Cash Acquisitions | -$17.2M | -- | -- | -$1B | -$790M | |
| Cash From Investing | -$30.9M | -$10.2M | -$12.2M | -$1B | -$809.5M | |
| Dividends Paid (Ex Special Dividend) | -$22.6M | -$29.7M | -$37.2M | -$38.8M | -$44.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $3.7M | -- | $899.4M | $778.7M | |
| Long-Term Debt Repaid | -$157.3M | -$2.3M | -$58.5M | $571K | -$71.6M | |
| Repurchase of Common Stock | -$717K | -$14.1M | -$29.1M | -$11.5M | $766K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$176.1M | -$34.8M | -$121.6M | $852.6M | $665.1M | |
| Beginning Cash (CF) | $221.8M | $174.2M | $128.7M | $143.1M | $165.3M | |
| Foreign Exchange Rate Adjustment | $1.1M | $225K | -$4.9M | -$8.4M | -$1.4M | |
| Additions / Reductions | -$14.6M | $125.5M | $39.7M | -$19.1M | -$48M | |
| Ending Cash (CF) | $208.3M | $300M | $163.5M | $115.7M | $116M | |
| Levered Free Cash Flow | $178M | $160.2M | $161.4M | $152.9M | $75.8M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $249.5M | $454.4M | $513.1M | $487.5M | $467.3M | |
| Depreciation & Amoritzation | $113.3M | $103.9M | $99.9M | $111.9M | $136.2M | |
| Stock-Based Compensation | $12.9M | $22.8M | $30.7M | $22.7M | $19M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $502.4M | $545.9M | $513.1M | $641.3M | $556.2M | |
| Capital Expenditures | $50.5M | $38.3M | $51.4M | $34.6M | $64.4M | |
| Cash Acquisitions | -$142.4M | -- | -$171.6M | -$1.4B | -$790M | |
| Cash From Investing | -$194.1M | -$33.2M | -$222.8M | -$1.4B | -$844.4M | |
| Dividends Paid (Ex Special Dividend) | -$88.3M | -$97.7M | -$125.9M | -$150.4M | -$161.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $9.4M | $63.1M | $2.2B | $783M | |
| Long-Term Debt Repaid | -$327.2M | -$305.5M | -$102.4M | -$1.2B | -$324.8M | |
| Repurchase of Common Stock | -$52.6M | -$61M | -$262.9M | -$89.7M | -$33.3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$251.5M | -$422.9M | -$416M | $750.5M | $294.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $56.8M | $89.8M | -$125.6M | -$45.1M | $6.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $451.9M | $507.6M | $461.7M | $606.7M | $491.8M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $454.4M | $513.1M | $487.5M | $467.3M | -- | |
| Depreciation & Amoritzation | $103.9M | $99.9M | $111.9M | $136.2M | -- | |
| Stock-Based Compensation | $22.8M | $30.7M | $22.7M | $19M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $545.9M | $513.1M | $641.3M | $556.2M | -- | |
| Capital Expenditures | $38.3M | $51.4M | $34.6M | $64.4M | -- | |
| Cash Acquisitions | -- | -$171.6M | -$1.4B | -$790M | -- | |
| Cash From Investing | -$33.2M | -$222.8M | -$1.4B | -$844.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -$97.7M | -$125.9M | -$150.4M | -$161.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $9.4M | $63.1M | $2.2B | $783M | -- | |
| Long-Term Debt Repaid | -$305.5M | -$102.4M | -$1.2B | -$324.8M | -- | |
| Repurchase of Common Stock | -$61M | -$262.9M | -$89.7M | -$33.3M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$422.9M | -$416M | $750.5M | $294.5M | -- | |
| Beginning Cash (CF) | $741.6M | $720.1M | $557.7M | $542.7M | -- | |
| Foreign Exchange Rate Adjustment | $1.8M | -$10.9M | -$2.7M | -$6M | -- | |
| Additions / Reductions | $89.8M | -$125.6M | -$45.1M | $6.3M | -- | |
| Ending Cash (CF) | $833.3M | $583.6M | $509.9M | $542.9M | -- | |
| Levered Free Cash Flow | $507.6M | $461.7M | $606.7M | $491.8M | -- | |
Get NDSN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NDSN
Sector
P/E ratio
25.86x
17.94x
PEG ratio
--
0.34x
P/B ratio
4.08x
1.76x
Price / LTM sales
4.49x
0.97x
Growth Metrics
NDSN
Sector
Revenue growth
3.5%
1.77%
Earnings growth
-4.51%
1.67%
Revenue (5-year growth)
4.16%
4.31%
Earnings forecast
$2.59
$0.46
Profitability
NDSN
Sector
Profitability FY 2024
$1.5B
$434.2M
Return on invested capital
10.39%
5.93%
Return on assets
8.69%
3.69%
Return on equity
16.81%
8.87%
Earnings Date
Last Earnings Date
Dec
11
Next Earnings Date
Feb
21
Estimated Next Earnings Date
Mar
12
Balance Sheet
NDSN
Sector
Total cash
$116M
$170.4M
Short term investments
--
$46.5M
Total assets
$6B
$2.1B
Long term debt
$2.2B
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
